Metraipolis › archive › dc_fa5126e2bd61

Impact of Immune-Related Adverse Event Frequency, Severity and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer — Europe PMC PMID:42192898

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42192898
DOI: 10.3390/cancers18101538
License (as archived): solo-consultazione
Archived: 2026-11-02T13:49:33.878Z
SHA-256 of the archived text: 29225656ecbcde99d194bc6440407b3d44a03465a3a938fa38765803fd995830
Stable URL of this page: https://metraipolis.com/documento/dc_fa5126e2bd61

How to cite

Impact of Immune-Related Adverse Event Frequency, Severity and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer — Europe PMC PMID:42192898 — Europe PMC (en), https://europepmc.org/article/MED/42192898 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa5126e2bd61 (Metraipolis archive dc_fa5126e2bd61, sha256 29225656ecbcde99d194bc6440407b3d44a03465a3a938fa38765803fd995830)

BibTeX

@misc{dcfa5126e2bd61,
  title = {Impact of Immune-Related Adverse Event Frequency, Severity and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer — Europe PMC PMID:42192898},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42192898},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa5126e2bd61; sha256 29225656ecbcde99d194bc6440407b3d44a03465a3a938fa38765803fd995830},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42192898. Agents can read the archived copy with the MCP tool read_document.